درباره این اپیزود
Ariana Thacker, is the founder and CEO of MoldCo—a company bringing real science, structure, and care to one of healthcare’s most overlooked crises: mold-related toxicity.
Ariana’s journey started in venture capital, leading Conscience VC with a focus on health, biotech, and consumer innovation.
But everything changed when a sudden toxicity derailed her life and exposed the massive gaps in how mainstream medicine treats environmental health.
What began as a personal search for answers evolved into MoldCo—a platform combining validated lab testing, clinician-led treatment, and the largest biobank in the field to redefine how mold toxicity is understood and treated.
We talked about Ariana’s shift from VC to founder, why mold was just the starting point for a broader vision around chronic microbial toxicity, and how MoldCo is building slow-moving science and fast-moving care under one roof.
Ariana also shared the genetic reasons some people get sick while others don’t, why traditional mold tests often fail, and the massive ripple effects she sees ahead across healthcare, real estate, and biotech.
Learn more about Ariana and her company below:
